Freedom Investment Management’s Integra LifeSciences IART Stock Holding History

Freedom Investment Management’s Portfolio IART Stock Details IART Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-3,135	Closed	-$214K	–	864
2021 Q2	$214K	Buy	3,135 +197	+7%	+$13.9K	0.02%	802
2021 Q1	$203K	Buy	+2,938	New	+$199K	0.02%	787
2019 Q4	–	Sell	-4,587	Closed	-$276K	–	685
2019 Q3	$276K	Buy	+4,587	New	+$273K	0.02%	538
2018 Q2	–	Sell	-8,086	Closed	-$447K	–	1026
2018 Q1	$447K	Buy	+8,086	New	+$424K	0.02%	672

Other funds holding IART

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

EVM

Eaton Vance Management Boston, Massachusetts $67.5B AUM 11.44% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Cooke & Bieler Philadelphia, Pennsylvania $8.84B AUM 6.92% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Freedom Investment Management's IART Position: Q3 2021 in Review

Freedom Investment Management sold out of Integra LifeSciences (IART) in Q3 2021, closing a stake of 3,135 shares — an estimated $214K sold.

Freedom Investment Management first reported a position in IART in Q1 2018 and held it in 4 quarters. The position peaked at $447K in Q1 2018. 261 funds tracked by Wall St. Rank hold IART as of Q3 2021.

Freedom Investment Management reported no remaining Integra LifeSciences position as of Q3 2021 after selling out during the quarter.
Freedom Investment Management sold 3,135 Integra LifeSciences shares in Q3 2021, an estimated $214K.
Freedom Investment Management first reported a position in Integra LifeSciences in Q1 2018 and held it in 4 quarters.
Freedom Investment Management's Integra LifeSciences position peaked at $447K in Q1 2018.
261 funds tracked by Wall St. Rank held Integra LifeSciences as of Q3 2021.

Based on Freedom Investment Management's 13F filing for Q3 2021, filed 12 Nov 2021.